Major League Baseball releases its annual drug report

Getty Images

Major League Baseball and the MLBPA just released their annual drug report, as required by the Joint Drug Agreement.

The notable numbers, which cover the period starting when the 2016 World Series ended until the 2017 World Series ended:

  • The total number of drug tests that were conducted during the 2017 Reporting Period was 10,237. Of this total number, 8,235 were urine samples for PEDs, stimulants and DHEA. There were 2,002 blood samples for HGH.
  • There were seven positive tests for players on 40-man rosters. Five for PEDs, two for stimulants;
  • 106 players were given therapeutic use exceptions which allow them to take otherwise banned drugs such as Adderall. Of these, 103 were for ADD, one was for azoospermia, which is a fertility disorder, one was for hypertension and one was for idiopathic hypersomnia, which is a sleep disorder in which a person is excessively sleepy during the day.’

As we always note, the number of players who got exemptions for ADD drugs is a bit higher than the occurrence of ADD in the population at large. But hey, if MLB is happy with the doctor’s notes they get, it’s good enough for me.

Tyler Glasnow scheduled to rejoin Rays’ rotation

Jonathan Dyer-USA TODAY Sports

ST. PETERSBURG, Fla. — Tampa Bay Rays right-hander Tyler Glasnow is scheduled to rejoin the rotation at Cleveland after missing nearly 14 months because of Tommy John surgery.

The Rays’ Opening Day starter last year hasn’t pitched this season after undergoing the procedure on Aug. 4, 2021.

“I think we’re pretty confident he’ll be starting for us,” Tampa Bay manager Kevin Cash said before the game with Toronto. “This is the first time he’s thrown pain-free in quite some time, so he’s encouraged by it.”

The 6-foot-8 right-hander went 5-2 with a 2.66 ERA in 14 starts last year and is a key addition as the Rays near a wild-card spot.

“Compared to the past, like, three years it feels way better as far as postday and the week leading into starts and stuff,” Glasnow said. “It’s good to have an UCL, you know.”

Cash said Glasnow will throw around 45 pitches in his initial outing, which should allow him to go two or three innings.

“Two innings of Glasnow is still a huge plus for our team,” Cash said. “Like to get three innings. If we do, great. If we don’t, that’s fine, too.”

Glasnow allowed one run, one hit, four walks and had 14 strikeouts over seven innings in four starts with Triple-A Durham.

“I’m really excited,” Glasnow said. “I’m approaching it like normal, staying on routine. Feels normal.”

Glasnow signed a two-year, $30.35 million contract that will delay the start of his free agency by one year last month. He’s making $5.1 million this year and will get $5.35 million next season and $25 million in 2024, which is the first year he would have been eligible for free agency.